INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Samsara BioCapital, LLC's Holding History (CIK: 0001744967)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 640,688 Value ($000) $11,878 Avg Close — Range —
Q2 2023
Shares 640,688 Value ($000) $7,086 Avg Close — Range —
Q1 2023
Shares 640,688 Value ($000) $8,604 Avg Close — Range —
Q4 2022
Shares 640,688 Value ($000) $7,925 Avg Close — Range —
Q3 2022
Shares 640,688 Value ($000) $8,938 Avg Close — Range —
Q2 2022
Shares 640,688 Value ($000) $8,848 Avg Close — Range —
Q1 2022
Shares 640,688 Value ($000) $10,424 Avg Close — Range —
Q4 2021
Shares 640,688 Value ($000) $10,437 Avg Close — Range —
Q3 2021
Shares 640,688 Value ($000) $9,514 Avg Close — Range —
Q2 2021
Shares 640,688 Value ($000) $12,795 Avg Close — Range —
Q1 2021
Shares 640,688 Value ($000) $14,787 Avg Close — Range —
Q4 2020
Shares 403,688 Value ($000) $9,971 Avg Close — Range —
Q3 2020
Shares 403,688 Value ($000) $16,737 Avg Close — Range —
Q2 2020
Shares 403,688 Value ($000) $19,341 Avg Close — Range —
Q1 2020
Shares 403,688 Value ($000) $25,416 Avg Close — Range —
Q4 2019
Shares 403,688 Value ($000) $50,025 Avg Close — Range —
Q3 2019
Shares 403,688 Value ($000) $26,789 Avg Close — Range —
Q2 2019
Shares 330,697 Value ($000) $26,314 Avg Close — Range —
Q1 2019
Shares 210,937 Value ($000) $23,595 Avg Close — Range —
Q4 2018
Shares 234,375 Value ($000) $23,623 Avg Close — Range —